The estimated Net Worth of Christopher P. Stewart is at least $213 Thousand dollars as of 12 May 2023. Mr Stewart owns over 50,000 units of Bionano Genomics Inc stock worth over $135,059 and over the last 4 years he sold BNGO stock worth over $0. In addition, he makes $77,932 as Chief Financial Officer at Bionano Genomics Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr Stewart BNGO stock SEC Form 4 insiders trading
Mr has made over 4 trades of the Bionano Genomics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of BNGO stock worth $33,500 on 12 May 2023.
The largest trade he's ever made was exercising 60,000 units of Bionano Genomics Inc stock on 13 May 2022 worth over $33,600. On average, Mr trades about 17,500 units every 80 days since 2020. As of 12 May 2023 he still owns at least 281,373 units of Bionano Genomics Inc stock.
You can see the complete history of Mr Stewart stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Christopher P. Stewart biography
Christopher P. Stewart is the Chief Financial Officer at Bionano Genomics Inc.
What is the salary of Mr Stewart?
As the Chief Financial Officer of Bionano Genomics Inc, the total compensation of Mr Stewart at Bionano Genomics Inc is $77,932. There are 4 executives at Bionano Genomics Inc getting paid more, with R. Erik Holmlin having the highest compensation of $898,590.
How old is Mr Stewart?
Mr Stewart is 50, he's been the Chief Financial Officer of Bionano Genomics Inc since . There are 6 older and 2 younger executives at Bionano Genomics Inc. The oldest executive at Bionano Genomics Inc is David Barker, 78, who is the Independent Chairman of the Board.
What's Mr Stewart's mailing address?
Christopher's mailing address filed with the SEC is C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121.
Insiders trading at Bionano Genomics Inc
Over the last 6 years, insiders at Bionano Genomics Inc have traded over $0 worth of Bionano Genomics Inc stock and bought 145,814 units worth $129,149 . The most active insiders traders include David L Barker, Christopher P. Stewart, and Christopher J Twomey. On average, Bionano Genomics Inc executives and independent directors trade stock every 75 days with the average trade being worth of $15,253. The most recent stock trade was executed by Hannah Mamuszka on 13 June 2023, trading 65,789 units of BNGO stock currently worth $50,000.
What does Bionano Genomics Inc do?
at bionano genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. our team is not afraid to venture into uncharted territory to look for answers. we welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. at bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality o
What does Bionano Genomics Inc's logo look like?
Complete history of Mr Stewart stock trades at Bionano Genomics Inc
Bionano Genomics Inc executives and stock owners
Bionano Genomics Inc executives and other stock owners filed with the SEC include:
-
R. Erik Holmlin,
President, Chief Executive Officer, Director -
Mark Oldakowski,
Chief Operating Officer -
Dr. Robert Erik Holmlin,
Pres, CEO, Sec. & Director -
David Barker,
Independent Chairman of the Board -
Christopher P. Stewart,
Chief Financial Officer -
Kristiina Vuori,
Independent Director -
Christopher Twomey,
Independent Director -
Albert Luderer,
Independent Director -
Hannah Mamuszka,
Director -
Yvonne Linney,
Director -
Alka Chaubey,
Chief Medical Officer -
Christopher Stewart,
Chief Financial Officer -
Dr. Charles Lee Ph.D.,
Scientific Advisor -
Prof. Pui-Yan Kwok,
Scientific Advisor -
Dr. Paul R. Selvin Ph.D.,
Scientific Advisor -
Mark Adamchak,
Controller -
Richard Shippy,
Chief Bus. Officer -
Robert J. Priar,
Chief Commercial Officer -
Dr. Alka Chaubey FACMG, Ph.D.,
Chief Medical Officer -
Aleksandar Rajkovic,
Director -
Robert J Priar,
Chief Commercial Officer -
Michael James Ward,
Former Chief Financial Officer -
Heather Adams,
Chief Administrative Officer -
Warren Robinson,
Chief Commercial Officer -
Darren Cai,
Director -
Quan Zhou,
Director -
Junfeng Wang,
Director -
Soheil Shams,
Chief Informatics Officer -
Richard Shippy,
Chief Business Officer -
Vincent Jung Fai Wong,
Director -
Jonathan V. Dixon,
GENERAL COUNSEL -
Gulsen Kama,
Chief Financial Officer